New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - caffeine 100mg (anhydrous); ergotamine tartrate 1mg;  ;   - tablet - 100 mg/1 mg - active: caffeine 100mg (anhydrous) ergotamine tartrate 1mg     excipient: iron oxide yellow magnesium stearate microcrystalline cellulose purified talc starch tartaric acid - treatment of acute attacks of migraine with or without aura in adults.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate oral solution is indicated for the short term treatment of apnea of prematurity in infants between 28 and <33 weeks gestational age. caffeine citrate is contraindicated in patients who have demonstrated hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

micro labs limited - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 60 mg in 3 ml - caffeine citrate injection usp is indicated for the treatment of apnea of prematurity. caffeine citrate injection usp is contraindicated in patients who have demonstrated hypersensitivity to any of its components.

Ireland - English - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - paracetamol; guaifenesin; caffeine anhydrous - capsule, hard - 500 mg/100 mg/25 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

United States - English - NLM (National Library of Medicine)

auromedics pharma llc - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate injection, usp is indicated for the treatment of apnea of prematurity. caffeine citrate injection is contraindicated in patients who have demonstrated hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate injection is indicated for the treatment of apnea of prematurity. caffeine citrate injection is contraindicated in patients who have demonstrated hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

sagent pharmaceuticals - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate is indicated for the treatment of apnea of prematurity. caffeine citrate is contraindicated in patients who have demonstrated hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate injection is indicated for the treatment of apnea of prematurity. caffeine citrate is contraindicated in patients who have demonstrated hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

american regent, inc. - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate injection is indicated for the treatment of apnea of prematurity. caffeine citrate injection is contraindicated in patients who have demonstrated hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

american regent, inc. - caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - caffeine 125 mg in 1 ml - caffeine and sodium benzoate injection has been used in conjunction with supportive measure to treat respiratory depression associated with overdosage with cns depressant drugs (e.g., narcotic analgesics, alcohol). however, because of questionable benefit and transient action, most authorities believe caffeine and other analeptics should not be used in these conditions and recommend other supportive therapy. none known.